ESR1 and breast carcinoma: Tamoxifen (Nolvadex or Soltamox), fulvestrant, and palbociclib are estrogen receptor blockers used to treat estrogen receptor-positive (ER+) breast cancer, which is a subtype of breast cancer that uses estrogen for cancer cell proliferation and disease progression [100].